Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $2.80 Billion |
|---|---|
| Enterprise Value | $1.77 Billion |
| Earnings per Share | $5.66 |
| Beta | 0.94 |
| Outstanding Shares | 227,883,789 |
| P/E Ratio | 12.02 |
|---|---|
| PEG | -20.34 |
| Price to Sales | 0.46 |
| Price to Book Ratio | 0.2 |
| Enterprise Value to Revenue | 0.29 |
| Enterprise Value to EBIT | 1.52 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.01 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in the research, production, and global distribution of vital, life-saving vaccines. The company's commercialized offerings include non-replicating vaccines for sm...